Assessment of Parkinson's disease.
The quantitative assessment of clinical deficits in Parkinson's disease has become more difficult due to such factors as the introduction of therapy that induces involuntary movements, the recognition of marked fluctuations in response to treatment, and an increasing of memory disturbance in patients. An attempt to take these problems into account using a brief and simple scale of evaluation is presented.
D000203:Activities of Daily Living; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D004185:Disability Evaluation; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D011795:Surveys and Questionnaires
D000978:Antiparkinson Agents